A Randomized Controlled Study on the Improvement of Medical Experience for Patients With Radiation-induced Oropharyngeal Mucositis Based on the RIS System of the Internet of Things

Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18-65
SponsorNanfang Hospital, Southern Medical University

About this trial

This study is a researcher-initiated, multi-center, prospective, two-arm interventional randomized controlled study across the country. It aims to explore whether an Internet of Things-based RIS system can enhance the medical experience of patients with radiation-induced oropharyngeal mucositis during the diagnosis and treatment process among head and neck cancer patients undergoing radiotherapy.

Eligibility criteria

Qualifiers

Voluntarily sign the informed consent form;

Reached the age of 18 on the date of signing the informed consent form, and under the age of 65;

Patients diagnosed with head and neck tumors and receiving radiotherapy as per the 2017 WHO standards and guidelines.

According to the doctor's assessment, patients may experience radiation-induced oropharyngeal mucositis during radiotherapy.

Disqualifiers

Have other uncontrolled serious diseases, such as unstable heart diseases requiring treatment, poorly controlled diabetes (fasting blood sugar > 1.5 times the upper limit of the normal value), mental disorders, and a severe history of allergies.

Trial design

Treatments tested in this trial

  • RIS system

Treatment groups

110 Participants
are divided into 2 treatment groups

Locations

4
Nanfang hospital, Southern medical university510515, GuangzhouGuangdong, China
Huizhou Central People's Hospital516000, HuizhouGuangdong, China
Jieyang people's hospital522000, JieyangGuangdong, China
Meizhou People's Hospital, Meizhou Academy of Medical Sciences Meizhou514000, MeizhouGuangdong, China

Sponsors and collaborators

Nanfang Hospital, Southern Medical University

Lead sponsor